Predictive Oncology Inc logo

Predictive Oncology Inc

$ 0.36 -0.0081 (-2.18%) 08:08 PM EST
P/E:
At Loss
P/B:
0.84
Market Cap:
$ 28.54M
Enterprise V:
$ 1.46M
Volume:
130.32K
Avg Vol (2M):
210.75K
Also Trade In:
Volume:
130.32K
Market Cap $:
28.54M
PE Ratio:
At Loss
Avg Vol (2-Month):
210.75K
Enterprise Value $:
1.46M
PB Ratio:
0.84
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.
Name Current Vs Industry Vs History
Cash-To-Debt 52.8
Equity-to-Asset 0.92
Debt-to-Equity 0.02
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.09
Distress
Grey
Safe
Beneish M-Score -2.03
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.31
9-Day RSI 33.65
14-Day RSI 37.93
6-1 Month Momentum % -59.9
12-1 Month Momentum % -67.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.56
Quick Ratio 10.39
Cash Ratio 10
Days Inventory 303.79
Days Sales Outstanding 70.53
Days Payable 759.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -259.8

Financials (Next Earnings Date:2022-11-10 Est.)

POAI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:POAI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.477
EPS (TTM) ($) -0.41
Beta 0.35
Volatility % 71.51
14-Day RSI 37.93
14-Day ATR ($) 0.030917
20-Day SMA ($) 0.38987
12-1 Month Momentum % -67.98
52-Week Range ($) 0.2486 - 1.4662
Shares Outstanding (Mil) 78.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Predictive Oncology Inc Filings

Document Form Filing Date
No Filing Data

Predictive Oncology Inc Analysis

Share your research

Headlines

See More
No news.